Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.3 USD | -2.18% | +0.03% | -3.49% |
11:46am | J&J: positive trial for Tremfya in ulcerative colitis | CF |
11:41am | Valneva Names New Chief Scientific Officer | MT |
Financials (USD)
Sales 2024 * | 88.37B | Sales 2025 * | 90.78B | Capitalization | 364B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B | Net income 2025 * | 23.09B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 131,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | -2.18% | ||
1 week | +0.03% | ||
Current month | +4.62% | ||
1 month | +2.27% | ||
3 months | -4.17% | ||
6 months | +0.91% | ||
Current year | -3.49% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 254 M€ | +10.44% | - | |
12.91% | 17 M€ | +7.97% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 151.3 | -2.18% | 7,742,280 |
24-05-17 | 154.6 | +0.23% | 6,521,794 |
24-05-16 | 154.3 | +1.05% | 7,590,959 |
24-05-15 | 152.7 | +0.85% | 5,547,955 |
24-05-14 | 151.4 | +0.11% | 8,254,171 |
Delayed Quote Nyse, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.49% | 364B | |
+34.35% | 705B | |
+31.11% | 583B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.43% | 238B | |
-3.27% | 210B | |
+10.25% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- JNJ Stock